prazosin has been researched along with Atrial Fibrillation in 4 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saxena, P | 1 |
| Myles, RC | 1 |
| Smith, GL | 1 |
| Workman, AJ | 1 |
| Irie, M | 1 |
| Tsuneoka, Y | 1 |
| Shimobayashi, M | 1 |
| Hasegawa, N | 2 |
| Tanaka, Y | 1 |
| Mochizuki, S | 1 |
| Ichige, S | 1 |
| Hamaguchi, S | 1 |
| Namekata, I | 1 |
| Tanaka, H | 1 |
| Suita, K | 1 |
| Fujita, T | 1 |
| Cai, W | 1 |
| Jin, H | 1 |
| Hidaka, Y | 1 |
| Prajapati, R | 1 |
| Umemura, M | 1 |
| Yokoyama, U | 1 |
| Sato, M | 1 |
| Okumura, S | 1 |
| Ishikawa, Y | 1 |
| Carson, PE | 1 |
| Johnson, GR | 1 |
| Dunkman, WB | 1 |
| Fletcher, RD | 1 |
| Farrell, L | 1 |
| Cohn, JN | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Congestive Heart Failure Atrial Arrhythmia Monitoring and Pacing (CHAMP)[NCT00156728] | Phase 4 | 172 participants | Interventional | 2003-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for prazosin and Atrial Fibrillation
| Article | Year |
|---|---|
The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group.
Topics: Atrial Fibrillation; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isoso | 1993 |
3 other studies available for prazosin and Atrial Fibrillation
| Article | Year |
|---|---|
Adrenoceptor sub-type involvement in Ca
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Atrial Fibrillation; Calcium Cha | 2022 |
Involvement of alpha- and beta-adrenoceptors in the automaticity of the isolated guinea pig pulmonary vein myocardium.
Topics: Animals; Atenolol; Atrial Fibrillation; Carbazoles; Carvedilol; Guinea Pigs; In Vitro Techniques; Ma | 2017 |
Norepinephrine-Induced Adrenergic Activation Strikingly Increased the Atrial Fibrillation Duration through β1- and α1-Adrenergic Receptor-Mediated Signaling in Mice.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Atrial Fibrillation; Calcium Sig | 2015 |